On September 3, 2020, Novan (NASDAQ:NOVN) announced that the first patient in the company’s pivotal Phase III trial, BSIMPLE-4, for lead candidate, SB206, in molluscum contagiosum (MC) had been ...

Please provide your email address to receive an email when new articles are posted on . MIAMI BEACH, Fla. — Two new treatment options for molluscum contagiosum could be available in the near future as ...

The U.S. Food Drug and Administration (FDA) has warned six companies — including Amazon and Walmart — over selling unapproved products marketed as treatments for a skin condition affecting children.